FDA Approves New Anti-Obesity Drug
September 23, 2014
Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.
Hypertension
Obesity, Hypertension Linked to Kidney Cancer Development
April 29, 2014
Results from two large cohorts indicated that increasing blood pressure levels were associated with an increased risk for developing kidney cancer among both men and women.
Ambulatory BP Helps Identify Resistant Hypertension
April 8, 2011
Ambulatory blood pressure monitoring is a useful prognosis tool to differentiate between true and white coat resistant hypertension, according to a study published online March 28 in Hypertension.
